Literature DB >> 21839333

Anaplastic lymphoma kinase expression in a recurrent primary cutaneous anaplastic large cell lymphoma with eventual systemic involvement.

Derek V Chan1, Pamela Summers2, Marie Tuttle2, Kevin D Cooper3, Brenda Cooper4, Henry Koon4, Kord Honda2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21839333      PMCID： PMC3156415          DOI： 10.1016/j.jaad.2010.06.016

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  5 in total

1.  Revised response criteria for malignant lymphoma.

Authors:  Bruce D Cheson; Beate Pfistner; Malik E Juweid; Randy D Gascoyne; Lena Specht; Sandra J Horning; Bertrand Coiffier; Richard I Fisher; Anton Hagenbeek; Emanuele Zucca; Steven T Rosen; Sigrid Stroobants; T Andrew Lister; Richard T Hoppe; Martin Dreyling; Kensei Tobinai; Julie M Vose; Joseph M Connors; Massimo Federico; Volker Diehl
Journal:  J Clin Oncol       Date:  2007-01-22       Impact factor: 44.544

Review 2.  WHO-EORTC classification for cutaneous lymphomas.

Authors:  Rein Willemze; Elaine S Jaffe; Günter Burg; Lorenzo Cerroni; Emilio Berti; Steven H Swerdlow; Elisabeth Ralfkiaer; Sergio Chimenti; José L Diaz-Perez; Lyn M Duncan; Florent Grange; Nancy Lee Harris; Werner Kempf; Helmut Kerl; Michael Kurrer; Robert Knobler; Nicola Pimpinelli; Christian Sander; Marco Santucci; Wolfram Sterry; Maarten H Vermeer; Janine Wechsler; Sean Whittaker; Chris J L M Meijer
Journal:  Blood       Date:  2005-02-03       Impact factor: 22.113

3.  Primary cutaneous ALCL with phosphorylated/activated cytoplasmic ALK and novel phenotype: EMA/MUC1+, cutaneous lymphocyte antigen negative.

Authors:  Marshall E Kadin; Jack L Pinkus; Geraldine S Pinkus; Ivan H Duran; Christine E Fuller; Mihaela Onciu; Hiroyuki Kawaguchi; Stephan W Morris
Journal:  Am J Surg Pathol       Date:  2008-09       Impact factor: 6.394

Review 4.  Anaplastic Large Cell Lymphoma.

Authors:  L Jeffrey Medeiros; Kojo S J Elenitoba-Johnson
Journal:  Am J Clin Pathol       Date:  2007-05       Impact factor: 2.493

Review 5.  Statistical evaluation of diagnostic and prognostic features of CD30+ cutaneous lymphoproliferative disorders: a clinicopathologic study of 65 cases.

Authors:  B Vergier; M Beylot-Barry; K Pulford; P Michel; J Bosq; A de Muret; C Beylot; M M Delaunay; M F Avril; S Dalac; C Bodemer; P Joly; A Groppi; A de Mascarel; M Bagot; D Y Mason; J Wechsler; J P Merlio
Journal:  Am J Surg Pathol       Date:  1998-10       Impact factor: 6.394
  5 in total
  3 in total

Review 1.  ALK-positive anaplastic large cell lymphoma limited to the skin: clinical, histopathological and molecular analysis of 6 pediatric cases. A report from the ALCL99 study.

Authors:  Ilske Oschlies; Jasmin Lisfeld; Laurence Lamant; Atsuko Nakazawa; Emanuele S G d'Amore; Ulrika Hansson; Konnie Hebeda; Ingrid Simonitsch-Klupp; Jadwiga Maldyk; Leonhard Müllauer; Marianne Tinguely; Markus Stücker; Marie-Cecile Ledeley; Reiner Siebert; Alfred Reiter; Laurence Brugières; Wolfram Klapper; Wilhelm Woessmann
Journal:  Haematologica       Date:  2012-07-06       Impact factor: 9.941

Review 2.  ALK-positive primary cutaneous anaplastic large cell lymphoma: a case report and review of the literature.

Authors:  Shamir Geller; Theresa N Canavan; Melissa Pulitzer; Alison J Moskowitz; Patricia L Myskowski
Journal:  Int J Dermatol       Date:  2017-10-23       Impact factor: 2.736

Review 3.  Anaplastic Lymphoma Kinase in Cutaneous Malignancies.

Authors:  Severine Cao; Vinod E Nambudiri
Journal:  Cancers (Basel)       Date:  2017-09-12       Impact factor: 6.639
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.